Target/Host (Institution) | Ligand | Target/Host Links | Ligand Links | Trg + Lig Links | Ki nM | ΔG° kJ/mole | IC50 nM | Kd nM | EC50/IC50 nM | koff s-1 | kon M-1s-1 | pH | Temp °C |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
ADP-ribosylhydrolase ARH3 (Homo sapiens (Human)) | BDBM421556![]() (3-[(4-Fluorophenyl)methyl]-N-(1-methylcyclopropyl)...) | PDB UniProtKB/SwissProt GoogleScholar AffyNet ![]() | PC cid PC sid UniChem | US Patent | n/a | n/a | >1.67E+4 | n/a | n/a | n/a | n/a | n/a | n/a |
Cancer Research Technology Limited US Patent | Assay Description ARH3 In vitro selectivity assays were conducted in a total volume of 15 ul in a standard 384 well format. 5 ul of Human Full Length ARH3 (Enzo Life S... | US Patent US10508086 (2019) BindingDB Entry DOI: 10.7270/Q26112QF | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
ADP-ribosylhydrolase ARH3 (Homo sapiens (Human)) | BDBM421539![]() (3-[(2,4-Dimethylthiazol-5-yl)methyl]-N-(1-methylcy...) | PDB UniProtKB/SwissProt GoogleScholar AffyNet ![]() | PC cid PC sid UniChem | US Patent | n/a | n/a | >1.67E+4 | n/a | n/a | n/a | n/a | n/a | n/a |
Cancer Research Technology Limited US Patent | Assay Description ARH3 In vitro selectivity assays were conducted in a total volume of 15 ul in a standard 384 well format. 5 ul of Human Full Length ARH3 (Enzo Life S... | US Patent US10508086 (2019) BindingDB Entry DOI: 10.7270/Q26112QF | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
ADP-ribosylhydrolase ARH3 (Homo sapiens (Human)) | BDBM421584![]() (3-[5-(difluoromethyl)-1,3,4-thiadiazol-2-yl]-6-flu...) | PDB UniProtKB/SwissProt GoogleScholar AffyNet ![]() | PC cid PC sid UniChem | US Patent | n/a | n/a | >5.00E+4 | n/a | n/a | n/a | n/a | n/a | n/a |
Cancer Research Technology Limited US Patent | Assay Description ARH3 In vitro selectivity assays were conducted in a total volume of 15 ul in a standard 384 well format. 5 ul of Human Full Length ARH3 (Enzo Life S... | US Patent US10508086 (2019) BindingDB Entry DOI: 10.7270/Q26112QF | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
ADP-ribosylhydrolase ARH3 (Homo sapiens (Human)) | BDBM421497![]() (US10508086, Example 87 | US10995073, Example 87) | PDB UniProtKB/SwissProt GoogleScholar AffyNet ![]() | PC cid PC sid UniChem | US Patent | n/a | n/a | 7.67E+4 | n/a | n/a | n/a | n/a | n/a | n/a |
Cancer Research Technology Limited US Patent | Assay Description ARH3 In vitro selectivity assays were conducted in a total volume of 15 ul in a standard 384 well format. 5 ul of Human Full Length ARH3 (Enzo Life S... | US Patent US10508086 (2019) BindingDB Entry DOI: 10.7270/Q26112QF | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
ADP-ribosylhydrolase ARH3 (Homo sapiens (Human)) | BDBM421492![]() (US10508086, Example 82 | US10995073, Example 82) | PDB UniProtKB/SwissProt GoogleScholar AffyNet ![]() | PC cid PC sid UniChem | US Patent | n/a | n/a | >1.00E+5 | n/a | n/a | n/a | n/a | n/a | n/a |
Cancer Research Technology Limited US Patent | Assay Description ARH3 In vitro selectivity assays were conducted in a total volume of 15 ul in a standard 384 well format. 5 ul of Human Full Length ARH3 (Enzo Life S... | US Patent US10508086 (2019) BindingDB Entry DOI: 10.7270/Q26112QF | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
ADP-ribosylhydrolase ARH3 (Homo sapiens (Human)) | BDBM421498![]() (US10508086, Example 88 | US10995073, Example 88) | PDB UniProtKB/SwissProt GoogleScholar AffyNet ![]() | PC cid PC sid UniChem | US Patent | n/a | n/a | >1.00E+5 | n/a | n/a | n/a | n/a | n/a | n/a |
Cancer Research Technology Limited US Patent | Assay Description ARH3 In vitro selectivity assays were conducted in a total volume of 15 ul in a standard 384 well format. 5 ul of Human Full Length ARH3 (Enzo Life S... | US Patent US10508086 (2019) BindingDB Entry DOI: 10.7270/Q26112QF | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
ADP-ribosylhydrolase ARH3 (Homo sapiens (Human)) | BDBM421488![]() (US10508086, Example 79 | US10995073, Example 79) | PDB UniProtKB/SwissProt GoogleScholar AffyNet ![]() | PC cid PC sid UniChem | US Patent | n/a | n/a | >1.00E+5 | n/a | n/a | n/a | n/a | n/a | n/a |
Cancer Research Technology Limited US Patent | Assay Description ARH3 In vitro selectivity assays were conducted in a total volume of 15 ul in a standard 384 well format. 5 ul of Human Full Length ARH3 (Enzo Life S... | US Patent US10508086 (2019) BindingDB Entry DOI: 10.7270/Q26112QF | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
ADP-ribosylhydrolase ARH3 (Homo sapiens (Human)) | BDBM421493![]() (US10508086, Example 83 | US10995073, Example 83) | PDB UniProtKB/SwissProt GoogleScholar AffyNet ![]() | PC cid PC sid UniChem | US Patent | n/a | n/a | >1.00E+5 | n/a | n/a | n/a | n/a | n/a | n/a |
Cancer Research Technology Limited US Patent | Assay Description ARH3 In vitro selectivity assays were conducted in a total volume of 15 ul in a standard 384 well format. 5 ul of Human Full Length ARH3 (Enzo Life S... | US Patent US10508086 (2019) BindingDB Entry DOI: 10.7270/Q26112QF | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
ADP-ribosylhydrolase ARH3 (Homo sapiens (Human)) | BDBM421482![]() (US10508086, Example 73 | US10995073, Example 73) | PDB UniProtKB/SwissProt GoogleScholar AffyNet ![]() | PC cid PC sid UniChem | US Patent | n/a | n/a | >1.00E+5 | n/a | n/a | n/a | n/a | n/a | n/a |
Cancer Research Technology Limited US Patent | Assay Description ARH3 In vitro selectivity assays were conducted in a total volume of 15 ul in a standard 384 well format. 5 ul of Human Full Length ARH3 (Enzo Life S... | US Patent US10508086 (2019) BindingDB Entry DOI: 10.7270/Q26112QF | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
ADP-ribosylhydrolase ARH3 (Homo sapiens (Human)) | BDBM205480![]() (PDD00017238 (5) | US10508086, Example 90 | US10995...) | PDB UniProtKB/SwissProt GoogleScholar AffyNet ![]() | Purchase MCE PC cid PC sid UniChem | US Patent | n/a | n/a | >1.00E+5 | n/a | n/a | n/a | n/a | n/a | n/a |
Cancer Research Technology Limited US Patent | Assay Description ARH3 In vitro selectivity assays were conducted in a total volume of 15 ul in a standard 384 well format. 5 ul of Human Full Length ARH3 (Enzo Life S... | US Patent US10508086 (2019) BindingDB Entry DOI: 10.7270/Q26112QF | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Poly [ADP-ribose] polymerase 1 (Homo sapiens (Human)) | BDBM421528![]() (US10508086, Example 118 | US10995073, Example 118) | PDB MMDB UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar AffyNet ![]() | PC cid PC sid UniChem | US Patent | n/a | n/a | >1.50E+5 | n/a | n/a | n/a | n/a | n/a | n/a |
Cancer Research Technology Limited US Patent | Assay Description PARP1 In vitro selectivity assays were conducted as a 10 ul reaction volume in a NUNC Maxisorp 384-well assay plate pre-coated in-house with Histones... | US Patent US10508086 (2019) BindingDB Entry DOI: 10.7270/Q26112QF | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
ADP-ribosylhydrolase ARH3 (Homo sapiens (Human)) | BDBM421529![]() (US10508086, Example 119 | US10995073, Example 119) | PDB UniProtKB/SwissProt GoogleScholar AffyNet ![]() | PC cid PC sid UniChem | US Patent | n/a | n/a | >1.50E+5 | n/a | n/a | n/a | n/a | n/a | n/a |
Cancer Research Technology Limited US Patent | Assay Description ARH3 In vitro selectivity assays were conducted in a total volume of 15 ul in a standard 384 well format. 5 ul of Human Full Length ARH3 (Enzo Life S... | US Patent US10508086 (2019) BindingDB Entry DOI: 10.7270/Q26112QF | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Poly [ADP-ribose] polymerase 1 (Homo sapiens (Human)) | BDBM421539![]() (3-[(2,4-Dimethylthiazol-5-yl)methyl]-N-(1-methylcy...) | PDB MMDB UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar AffyNet ![]() | PC cid PC sid UniChem | US Patent | n/a | n/a | >1.50E+5 | n/a | n/a | n/a | n/a | n/a | n/a |
Cancer Research Technology Limited US Patent | Assay Description PARP1 In vitro selectivity assays were conducted as a 10 ul reaction volume in a NUNC Maxisorp 384-well assay plate pre-coated in-house with Histones... | US Patent US10508086 (2019) BindingDB Entry DOI: 10.7270/Q26112QF | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Poly [ADP-ribose] polymerase 1 (Homo sapiens (Human)) | BDBM421529![]() (US10508086, Example 119 | US10995073, Example 119) | PDB MMDB UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar AffyNet ![]() | PC cid PC sid UniChem | US Patent | n/a | n/a | >1.50E+5 | n/a | n/a | n/a | n/a | n/a | n/a |
Cancer Research Technology Limited US Patent | Assay Description PARP1 In vitro selectivity assays were conducted as a 10 ul reaction volume in a NUNC Maxisorp 384-well assay plate pre-coated in-house with Histones... | US Patent US10508086 (2019) BindingDB Entry DOI: 10.7270/Q26112QF | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
ADP-ribosylhydrolase ARH3 (Homo sapiens (Human)) | BDBM421555![]() (3-(Cyclopropanecarbonyl)-1-[5-(difluoromethyl)-1,3...) | PDB UniProtKB/SwissProt GoogleScholar AffyNet ![]() | PC cid PC sid UniChem | US Patent | n/a | n/a | >1.50E+5 | n/a | n/a | n/a | n/a | n/a | n/a |
Cancer Research Technology Limited US Patent | Assay Description ARH3 In vitro selectivity assays were conducted in a total volume of 15 ul in a standard 384 well format. 5 ul of Human Full Length ARH3 (Enzo Life S... | US Patent US10508086 (2019) BindingDB Entry DOI: 10.7270/Q26112QF | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Poly [ADP-ribose] polymerase 1 (Homo sapiens (Human)) | BDBM421555![]() (3-(Cyclopropanecarbonyl)-1-[5-(difluoromethyl)-1,3...) | PDB MMDB UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar AffyNet ![]() | PC cid PC sid UniChem | US Patent | n/a | n/a | >1.50E+5 | n/a | n/a | n/a | n/a | n/a | n/a |
Cancer Research Technology Limited US Patent | Assay Description PARP1 In vitro selectivity assays were conducted as a 10 ul reaction volume in a NUNC Maxisorp 384-well assay plate pre-coated in-house with Histones... | US Patent US10508086 (2019) BindingDB Entry DOI: 10.7270/Q26112QF | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Poly [ADP-ribose] polymerase 1 (Homo sapiens (Human)) | BDBM421556![]() (3-[(4-Fluorophenyl)methyl]-N-(1-methylcyclopropyl)...) | PDB MMDB UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar AffyNet ![]() | PC cid PC sid UniChem | US Patent | n/a | n/a | >1.50E+5 | n/a | n/a | n/a | n/a | n/a | n/a |
Cancer Research Technology Limited US Patent | Assay Description PARP1 In vitro selectivity assays were conducted as a 10 ul reaction volume in a NUNC Maxisorp 384-well assay plate pre-coated in-house with Histones... | US Patent US10508086 (2019) BindingDB Entry DOI: 10.7270/Q26112QF | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Poly [ADP-ribose] polymerase 1 (Homo sapiens (Human)) | BDBM421584![]() (3-[5-(difluoromethyl)-1,3,4-thiadiazol-2-yl]-6-flu...) | PDB MMDB UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar AffyNet ![]() | PC cid PC sid UniChem | US Patent | n/a | n/a | >1.50E+5 | n/a | n/a | n/a | n/a | n/a | n/a |
Cancer Research Technology Limited US Patent | Assay Description PARP1 In vitro selectivity assays were conducted as a 10 ul reaction volume in a NUNC Maxisorp 384-well assay plate pre-coated in-house with Histones... | US Patent US10508086 (2019) BindingDB Entry DOI: 10.7270/Q26112QF | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
ADP-ribosylhydrolase ARH3 (Homo sapiens (Human)) | BDBM421610![]() (3-[5-(Difluoromethyl)-1,3,4-oxadiazol-2-yl]-1-ethy...) | PDB UniProtKB/SwissProt GoogleScholar AffyNet ![]() | PC cid PC sid UniChem | US Patent | n/a | n/a | >1.50E+5 | n/a | n/a | n/a | n/a | n/a | n/a |
Cancer Research Technology Limited US Patent | Assay Description ARH3 In vitro selectivity assays were conducted in a total volume of 15 ul in a standard 384 well format. 5 ul of Human Full Length ARH3 (Enzo Life S... | US Patent US10508086 (2019) BindingDB Entry DOI: 10.7270/Q26112QF | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
ADP-ribosylhydrolase ARH3 (Homo sapiens (Human)) | BDBM421618![]() (3-[5-(Difluoromethyl)-1,3,4-thiadiazol-2-yl]-1-eth...) | PDB UniProtKB/SwissProt GoogleScholar AffyNet ![]() | PC cid PC sid UniChem | US Patent | n/a | n/a | >1.50E+5 | n/a | n/a | n/a | n/a | n/a | n/a |
Cancer Research Technology Limited US Patent | Assay Description ARH3 In vitro selectivity assays were conducted in a total volume of 15 ul in a standard 384 well format. 5 ul of Human Full Length ARH3 (Enzo Life S... | US Patent US10508086 (2019) BindingDB Entry DOI: 10.7270/Q26112QF | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Poly [ADP-ribose] polymerase 1 (Homo sapiens (Human)) | BDBM421618![]() (3-[5-(Difluoromethyl)-1,3,4-thiadiazol-2-yl]-1-eth...) | PDB MMDB UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar AffyNet ![]() | PC cid PC sid UniChem | US Patent | n/a | n/a | >1.50E+5 | n/a | n/a | n/a | n/a | n/a | n/a |
Cancer Research Technology Limited US Patent | Assay Description PARP1 In vitro selectivity assays were conducted as a 10 ul reaction volume in a NUNC Maxisorp 384-well assay plate pre-coated in-house with Histones... | US Patent US10508086 (2019) BindingDB Entry DOI: 10.7270/Q26112QF | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
ADP-ribosylhydrolase ARH3 (Homo sapiens (Human)) | BDBM421621![]() (US10508086, Example 211 | US10995073, Example 211) | PDB UniProtKB/SwissProt GoogleScholar AffyNet ![]() | PC cid PC sid UniChem | US Patent | n/a | n/a | >1.50E+5 | n/a | n/a | n/a | n/a | n/a | n/a |
Cancer Research Technology Limited US Patent | Assay Description ARH3 In vitro selectivity assays were conducted in a total volume of 15 ul in a standard 384 well format. 5 ul of Human Full Length ARH3 (Enzo Life S... | US Patent US10508086 (2019) BindingDB Entry DOI: 10.7270/Q26112QF | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
ADP-ribosylhydrolase ARH3 (Homo sapiens (Human)) | BDBM421622![]() (3-[5-(Difluoromethyl)-1,3,4-oxadiazol-2-yl]-6-fluo...) | PDB UniProtKB/SwissProt GoogleScholar AffyNet ![]() | PC cid PC sid UniChem | US Patent | n/a | n/a | >1.50E+5 | n/a | n/a | n/a | n/a | n/a | n/a |
Cancer Research Technology Limited US Patent | Assay Description ARH3 In vitro selectivity assays were conducted in a total volume of 15 ul in a standard 384 well format. 5 ul of Human Full Length ARH3 (Enzo Life S... | US Patent US10508086 (2019) BindingDB Entry DOI: 10.7270/Q26112QF | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
ADP-ribosylhydrolase ARH3 (Homo sapiens (Human)) | BDBM421623![]() (US10508086, Example 213 | US10995073, Example 213) | PDB UniProtKB/SwissProt GoogleScholar AffyNet ![]() | PC cid PC sid UniChem | US Patent | n/a | n/a | >1.50E+5 | n/a | n/a | n/a | n/a | n/a | n/a |
Cancer Research Technology Limited US Patent | Assay Description ARH3 In vitro selectivity assays were conducted in a total volume of 15 ul in a standard 384 well format. 5 ul of Human Full Length ARH3 (Enzo Life S... | US Patent US10508086 (2019) BindingDB Entry DOI: 10.7270/Q26112QF | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
ADP-ribosylhydrolase ARH3 (Homo sapiens (Human)) | BDBM421528![]() (US10508086, Example 118 | US10995073, Example 118) | PDB UniProtKB/SwissProt GoogleScholar AffyNet ![]() | PC cid PC sid UniChem | US Patent | n/a | n/a | >1.50E+5 | n/a | n/a | n/a | n/a | n/a | n/a |
Cancer Research Technology Limited US Patent | Assay Description ARH3 In vitro selectivity assays were conducted in a total volume of 15 ul in a standard 384 well format. 5 ul of Human Full Length ARH3 (Enzo Life S... | US Patent US10508086 (2019) BindingDB Entry DOI: 10.7270/Q26112QF | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Poly [ADP-ribose] polymerase 1 (Homo sapiens (Human)) | BDBM421423![]() (N-(1-Methylcyclopropyl)-1-[2-(2-oxooxazolidin-3-yl...) | PDB MMDB UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar AffyNet ![]() | PC cid PC sid UniChem | US Patent | n/a | n/a | >1.50E+5 | n/a | n/a | n/a | n/a | n/a | n/a |
Cancer Research Technology Limited US Patent | Assay Description PARP1 In vitro selectivity assays were conducted as a 10 ul reaction volume in a NUNC Maxisorp 384-well assay plate pre-coated in-house with Histones... | US Patent US10508086 (2019) BindingDB Entry DOI: 10.7270/Q26112QF | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
ADP-ribosylhydrolase ARH3 (Homo sapiens (Human)) | BDBM421423![]() (N-(1-Methylcyclopropyl)-1-[2-(2-oxooxazolidin-3-yl...) | PDB UniProtKB/SwissProt GoogleScholar AffyNet ![]() | PC cid PC sid UniChem | US Patent | n/a | n/a | >1.50E+5 | n/a | n/a | n/a | n/a | n/a | n/a |
Cancer Research Technology Limited US Patent | Assay Description ARH3 In vitro selectivity assays were conducted in a total volume of 15 ul in a standard 384 well format. 5 ul of Human Full Length ARH3 (Enzo Life S... | US Patent US10508086 (2019) BindingDB Entry DOI: 10.7270/Q26112QF | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Poly [ADP-ribose] polymerase 1 (Homo sapiens (Human)) | BDBM205480![]() (PDD00017238 (5) | US10508086, Example 90 | US10995...) | PDB MMDB UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar AffyNet ![]() | Purchase MCE PC cid PC sid UniChem | US Patent | n/a | n/a | >1.50E+5 | n/a | n/a | n/a | n/a | n/a | n/a |
Cancer Research Technology Limited US Patent | Assay Description PARP1 In vitro selectivity assays were conducted as a 10 ul reaction volume in a NUNC Maxisorp 384-well assay plate pre-coated in-house with Histones... | US Patent US10508086 (2019) BindingDB Entry DOI: 10.7270/Q26112QF | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Poly [ADP-ribose] polymerase 1 (Homo sapiens (Human)) | BDBM421498![]() (US10508086, Example 88 | US10995073, Example 88) | PDB MMDB UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar AffyNet ![]() | PC cid PC sid UniChem | US Patent | n/a | n/a | >1.50E+5 | n/a | n/a | n/a | n/a | n/a | n/a |
Cancer Research Technology Limited US Patent | Assay Description PARP1 In vitro selectivity assays were conducted as a 10 ul reaction volume in a NUNC Maxisorp 384-well assay plate pre-coated in-house with Histones... | US Patent US10508086 (2019) BindingDB Entry DOI: 10.7270/Q26112QF | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Poly [ADP-ribose] polymerase 1 (Homo sapiens (Human)) | BDBM421497![]() (US10508086, Example 87 | US10995073, Example 87) | PDB MMDB UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar AffyNet ![]() | PC cid PC sid UniChem | US Patent | n/a | n/a | >1.50E+5 | n/a | n/a | n/a | n/a | n/a | n/a |
Cancer Research Technology Limited US Patent | Assay Description PARP1 In vitro selectivity assays were conducted as a 10 ul reaction volume in a NUNC Maxisorp 384-well assay plate pre-coated in-house with Histones... | US Patent US10508086 (2019) BindingDB Entry DOI: 10.7270/Q26112QF | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Poly [ADP-ribose] polymerase 1 (Homo sapiens (Human)) | BDBM421493![]() (US10508086, Example 83 | US10995073, Example 83) | PDB MMDB UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar AffyNet ![]() | PC cid PC sid UniChem | US Patent | n/a | n/a | >1.50E+5 | n/a | n/a | n/a | n/a | n/a | n/a |
Cancer Research Technology Limited US Patent | Assay Description PARP1 In vitro selectivity assays were conducted as a 10 ul reaction volume in a NUNC Maxisorp 384-well assay plate pre-coated in-house with Histones... | US Patent US10508086 (2019) BindingDB Entry DOI: 10.7270/Q26112QF | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Poly [ADP-ribose] polymerase 1 (Homo sapiens (Human)) | BDBM421492![]() (US10508086, Example 82 | US10995073, Example 82) | PDB MMDB UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar AffyNet ![]() | PC cid PC sid UniChem | US Patent | n/a | n/a | >1.50E+5 | n/a | n/a | n/a | n/a | n/a | n/a |
Cancer Research Technology Limited US Patent | Assay Description PARP1 In vitro selectivity assays were conducted as a 10 ul reaction volume in a NUNC Maxisorp 384-well assay plate pre-coated in-house with Histones... | US Patent US10508086 (2019) BindingDB Entry DOI: 10.7270/Q26112QF | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Poly [ADP-ribose] polymerase 1 (Homo sapiens (Human)) | BDBM421488![]() (US10508086, Example 79 | US10995073, Example 79) | PDB MMDB UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar AffyNet ![]() | PC cid PC sid UniChem | US Patent | n/a | n/a | >1.50E+5 | n/a | n/a | n/a | n/a | n/a | n/a |
Cancer Research Technology Limited US Patent | Assay Description PARP1 In vitro selectivity assays were conducted as a 10 ul reaction volume in a NUNC Maxisorp 384-well assay plate pre-coated in-house with Histones... | US Patent US10508086 (2019) BindingDB Entry DOI: 10.7270/Q26112QF | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
ADP-ribosylhydrolase ARH3 (Homo sapiens (Human)) | BDBM421626![]() (3-[5-(Difluoromethyl)-1,3,4-thiadiazol-2-yl]-6-flu...) | PDB UniProtKB/SwissProt GoogleScholar AffyNet ![]() | PC cid PC sid UniChem | US Patent | n/a | n/a | >1.50E+5 | n/a | n/a | n/a | n/a | n/a | n/a |
Cancer Research Technology Limited US Patent | Assay Description ARH3 In vitro selectivity assays were conducted in a total volume of 15 ul in a standard 384 well format. 5 ul of Human Full Length ARH3 (Enzo Life S... | US Patent US10508086 (2019) BindingDB Entry DOI: 10.7270/Q26112QF | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Poly [ADP-ribose] polymerase 1 (Homo sapiens (Human)) | BDBM421482![]() (US10508086, Example 73 | US10995073, Example 73) | PDB MMDB UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar AffyNet ![]() | PC cid PC sid UniChem | US Patent | n/a | n/a | >1.50E+5 | n/a | n/a | n/a | n/a | n/a | n/a |
Cancer Research Technology Limited US Patent | Assay Description PARP1 In vitro selectivity assays were conducted as a 10 ul reaction volume in a NUNC Maxisorp 384-well assay plate pre-coated in-house with Histones... | US Patent US10508086 (2019) BindingDB Entry DOI: 10.7270/Q26112QF | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Poly(ADP-ribose) glycohydrolase (Homo sapiens (Human)) | BDBM421410![]() (US10508086, Example 1 | US10995073, Example 1) | PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet ![]() | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 9.41E+3 | n/a | n/a | n/a | n/a |
Cancer Research Technology Limited US Patent | Assay Description PARG In vitro assays were conducted in a total volume of 15 ul in a standard 384 well format. 5 ul of Human Full Length PARG (Produced internally by ... | US Patent US10508086 (2019) BindingDB Entry DOI: 10.7270/Q26112QF | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Poly(ADP-ribose) glycohydrolase (Homo sapiens (Human)) | BDBM421411![]() (US10508086, Example 2 | US10995073, Example 2) | PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet ![]() | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 5.00E+3 | n/a | n/a | n/a | n/a |
Cancer Research Technology Limited US Patent | Assay Description PARG In vitro assays were conducted in a total volume of 15 ul in a standard 384 well format. 5 ul of Human Full Length PARG (Produced internally by ... | US Patent US10508086 (2019) BindingDB Entry DOI: 10.7270/Q26112QF | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Poly(ADP-ribose) glycohydrolase (Homo sapiens (Human)) | BDBM421412![]() (US10508086, Example 3 | US10995073, Example 3) | PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet ![]() | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 8.28E+3 | n/a | n/a | n/a | n/a |
Cancer Research Technology Limited US Patent | Assay Description PARG In vitro assays were conducted in a total volume of 15 ul in a standard 384 well format. 5 ul of Human Full Length PARG (Produced internally by ... | US Patent US10508086 (2019) BindingDB Entry DOI: 10.7270/Q26112QF | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Poly(ADP-ribose) glycohydrolase (Homo sapiens (Human)) | BDBM421413![]() (US10508086, Example 4 | US10995073, Example 4) | PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet ![]() | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 2.91E+3 | n/a | n/a | n/a | n/a |
Cancer Research Technology Limited US Patent | Assay Description PARG In vitro assays were conducted in a total volume of 15 ul in a standard 384 well format. 5 ul of Human Full Length PARG (Produced internally by ... | US Patent US10508086 (2019) BindingDB Entry DOI: 10.7270/Q26112QF | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Poly(ADP-ribose) glycohydrolase (Homo sapiens (Human)) | BDBM421414![]() (US10508086, Example 5 | US10995073, Example 5) | PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet ![]() | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 6.76E+3 | n/a | n/a | n/a | n/a |
Cancer Research Technology Limited US Patent | Assay Description PARG In vitro assays were conducted in a total volume of 15 ul in a standard 384 well format. 5 ul of Human Full Length PARG (Produced internally by ... | US Patent US10508086 (2019) BindingDB Entry DOI: 10.7270/Q26112QF | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Poly(ADP-ribose) glycohydrolase (Homo sapiens (Human)) | BDBM421415![]() (US10508086, Example 6 | US10995073, Example 6) | PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet ![]() | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 8.32E+3 | n/a | n/a | n/a | n/a |
Cancer Research Technology Limited US Patent | Assay Description PARG In vitro assays were conducted in a total volume of 15 ul in a standard 384 well format. 5 ul of Human Full Length PARG (Produced internally by ... | US Patent US10508086 (2019) BindingDB Entry DOI: 10.7270/Q26112QF | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Poly(ADP-ribose) glycohydrolase (Homo sapiens (Human)) | BDBM421416![]() (US10508086, Example 7 | US10995073, Example 7) | PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet ![]() | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 9.79E+3 | n/a | n/a | n/a | n/a |
Cancer Research Technology Limited US Patent | Assay Description PARG In vitro assays were conducted in a total volume of 15 ul in a standard 384 well format. 5 ul of Human Full Length PARG (Produced internally by ... | US Patent US10508086 (2019) BindingDB Entry DOI: 10.7270/Q26112QF | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Poly(ADP-ribose) glycohydrolase (Homo sapiens (Human)) | BDBM421417![]() (US10508086, Example 8 | US10995073, Example 8) | PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet ![]() | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 4.51E+3 | n/a | n/a | n/a | n/a |
Cancer Research Technology Limited US Patent | Assay Description PARG In vitro assays were conducted in a total volume of 15 ul in a standard 384 well format. 5 ul of Human Full Length PARG (Produced internally by ... | US Patent US10508086 (2019) BindingDB Entry DOI: 10.7270/Q26112QF | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Poly(ADP-ribose) glycohydrolase (Homo sapiens (Human)) | BDBM421418![]() (US10508086, Example 9 | US10995073, Example 9) | PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet ![]() | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 4.04E+3 | n/a | n/a | n/a | n/a |
Cancer Research Technology Limited US Patent | Assay Description PARG In vitro assays were conducted in a total volume of 15 ul in a standard 384 well format. 5 ul of Human Full Length PARG (Produced internally by ... | US Patent US10508086 (2019) BindingDB Entry DOI: 10.7270/Q26112QF | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Poly(ADP-ribose) glycohydrolase (Homo sapiens (Human)) | BDBM421419![]() (US10508086, Example 10 | US10995073, Example 10) | PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet ![]() | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 8.42E+3 | n/a | n/a | n/a | n/a |
Cancer Research Technology Limited US Patent | Assay Description PARG In vitro assays were conducted in a total volume of 15 ul in a standard 384 well format. 5 ul of Human Full Length PARG (Produced internally by ... | US Patent US10508086 (2019) BindingDB Entry DOI: 10.7270/Q26112QF | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Poly(ADP-ribose) glycohydrolase (Homo sapiens (Human)) | BDBM421420![]() (US10508086, Example 11 | US10995073, Example 11) | PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet ![]() | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 4.67E+3 | n/a | n/a | n/a | n/a |
Cancer Research Technology Limited US Patent | Assay Description PARG In vitro assays were conducted in a total volume of 15 ul in a standard 384 well format. 5 ul of Human Full Length PARG (Produced internally by ... | US Patent US10508086 (2019) BindingDB Entry DOI: 10.7270/Q26112QF | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Poly(ADP-ribose) glycohydrolase (Homo sapiens (Human)) | BDBM421421![]() (US10508086, Example 12 | US10995073, Example 12) | PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet ![]() | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 8.29E+3 | n/a | n/a | n/a | n/a |
Cancer Research Technology Limited US Patent | Assay Description PARG In vitro assays were conducted in a total volume of 15 ul in a standard 384 well format. 5 ul of Human Full Length PARG (Produced internally by ... | US Patent US10508086 (2019) BindingDB Entry DOI: 10.7270/Q26112QF | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Poly(ADP-ribose) glycohydrolase (Homo sapiens (Human)) | BDBM421422![]() (US10508086, Example 13 | US10995073, Example 13) | PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet ![]() | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 7.12E+3 | n/a | n/a | n/a | n/a |
Cancer Research Technology Limited US Patent | Assay Description PARG In vitro assays were conducted in a total volume of 15 ul in a standard 384 well format. 5 ul of Human Full Length PARG (Produced internally by ... | US Patent US10508086 (2019) BindingDB Entry DOI: 10.7270/Q26112QF | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Poly(ADP-ribose) glycohydrolase (Homo sapiens (Human)) | BDBM421423![]() (N-(1-Methylcyclopropyl)-1-[2-(2-oxooxazolidin-3-yl...) | PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet ![]() | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 4.28E+3 | n/a | n/a | n/a | n/a |
Cancer Research Technology Limited US Patent | Assay Description PARG In vitro assays were conducted in a total volume of 15 ul in a standard 384 well format. 5 ul of Human Full Length PARG (Produced internally by ... | US Patent US10508086 (2019) BindingDB Entry DOI: 10.7270/Q26112QF | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Poly(ADP-ribose) glycohydrolase (Homo sapiens (Human)) | BDBM421424![]() (US10508086, Example 15 | US10995073, Example 15) | PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet ![]() | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 6.59E+3 | n/a | n/a | n/a | n/a |
Cancer Research Technology Limited US Patent | Assay Description PARG In vitro assays were conducted in a total volume of 15 ul in a standard 384 well format. 5 ul of Human Full Length PARG (Produced internally by ... | US Patent US10508086 (2019) BindingDB Entry DOI: 10.7270/Q26112QF | |||||||||||
More data for this Ligand-Target Pair |
Displayed 1 to 50 (of 253 total ) | Next | Last >> |